News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
579,873 Results
Type
Article (55267)
Company Profile (185)
Press Release (524421)
Multimedia
Podcasts (70)
Webinars (11)
Section
Business (169800)
Career Advice (1707)
Deals (28476)
Drug Delivery (93)
Drug Development (64892)
Employer Resources (116)
FDA (11736)
Job Trends (13185)
News (280587)
Policy (25609)
Tag
Academia (2765)
Academic (1)
Accelerated approval (5)
Adcomms (15)
Allergies (73)
Alliances (46486)
ALS (81)
Alzheimer's disease (1248)
Antibody-drug conjugate (ADC) (108)
Approvals (11767)
Artificial intelligence (252)
Autoimmune disease (15)
Automation (11)
Bankruptcy (253)
Best Places to Work (10161)
BIOSECURE Act (17)
Biosimilars (75)
Biotechnology (89)
Bladder cancer (50)
Brain cancer (28)
Breast cancer (234)
Cancer (1891)
Cardiovascular disease (149)
Career advice (1426)
Career pathing (27)
CAR-T (117)
Cell therapy (333)
Cervical cancer (16)
Clinical research (51947)
Collaboration (800)
Compensation (381)
Complete response letters (20)
COVID-19 (2263)
CRISPR (39)
C-suite (211)
Cystic fibrosis (83)
Data (1851)
Decentralized trials (2)
Denatured (26)
Depression (33)
Diabetes (198)
Diagnostics (5365)
Digital health (16)
Diversity (7)
Diversity, equity & inclusion (28)
Drug discovery (111)
Drug pricing (101)
Drug shortages (18)
Duchenne muscular dystrophy (73)
Earnings (62751)
Editorial (34)
Employer branding (17)
Employer resources (100)
Events (79068)
Executive appointments (682)
FDA (12792)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (614)
Gene editing (85)
Generative AI (21)
Gene therapy (262)
GLP-1 (585)
Government (3771)
Grass and pollen (6)
Guidances (136)
Healthcare (15744)
Huntington's disease (12)
IgA nephropathy (15)
Immunology and inflammation (79)
Indications (24)
Infectious disease (2379)
Inflammatory bowel disease (111)
Inflation Reduction Act (8)
Influenza (45)
Intellectual property (83)
Interviews (316)
IPO (12378)
IRA (45)
Job creations (3391)
Job search strategy (1223)
Kidney cancer (7)
Labor market (34)
Layoffs (373)
Leadership (13)
Legal (5728)
Liver cancer (50)
Lung cancer (263)
Lymphoma (134)
Machine learning (8)
Management (35)
Manufacturing (289)
MASH (62)
Medical device (8704)
Medtech (8709)
Mergers & acquisitions (16584)
Metabolic disorders (516)
Multiple sclerosis (63)
NASH (16)
Neurodegenerative disease (68)
Neuropsychiatric disorders (15)
Neuroscience (1691)
NextGen: Class of 2025 (5660)
Non-profit (4460)
Now hiring (29)
Obesity (257)
Opinion (193)
Ovarian cancer (67)
Pain (82)
Pancreatic cancer (64)
Parkinson's disease (120)
Partnered (20)
Patents (193)
Patient recruitment (86)
Peanut (34)
People (51089)
Pharmaceutical (75)
Pharmacy benefit managers (14)
Phase I (15601)
Phase II (22531)
Phase III (17635)
Pipeline (1187)
Policy (150)
Postmarket research (2371)
Preclinical (7776)
Press Release (70)
Prostate cancer (89)
Psychedelics (28)
Radiopharmaceuticals (212)
Rare diseases (305)
Real estate (5750)
Recruiting (45)
Regulatory (17847)
Reports (30)
Research institute (2571)
Resumes & cover letters (256)
Rett syndrome (2)
RNA editing (2)
RSV (25)
Schizophrenia (66)
Series A (92)
Series B (54)
Service/supplier (20)
Sickle cell disease (47)
Special edition (18)
Spinal muscular atrophy (129)
Sponsored (28)
Startups (3040)
State (2)
Stomach cancer (4)
Supply chain (55)
Tariffs (47)
The Weekly (42)
Vaccines (576)
Venture capitalists (25)
Weight loss (155)
Women's health (27)
Worklife (11)
Date
Last 7 days (769)
Last 30 days (2342)
Last 365 days (25502)
2025 (9246)
2024 (27780)
2023 (32053)
2022 (42519)
2021 (46024)
2020 (45282)
2019 (40202)
2018 (30561)
2017 (27404)
2016 (27394)
2015 (32146)
2014 (25584)
2013 (22473)
2012 (23038)
2011 (23884)
2010 (22168)
Location
Africa (734)
Alabama (53)
Alaska (6)
Arizona (151)
Arkansas (10)
Asia (35794)
Australia (5927)
California (4570)
Canada (1775)
China (431)
Colorado (227)
Connecticut (213)
Delaware (121)
Europe (79667)
Florida (755)
Georgia (160)
Hawaii (1)
Idaho (36)
Illinois (490)
India (25)
Indiana (243)
Iowa (8)
Japan (160)
Kansas (90)
Kentucky (25)
Louisiana (11)
Maine (35)
Maryland (723)
Massachusetts (3459)
Michigan (191)
Minnesota (273)
Mississippi (2)
Missouri (68)
Montana (26)
Nebraska (20)
Nevada (48)
New Hampshire (35)
New Jersey (1486)
New Mexico (28)
New York (1418)
North Carolina (883)
North Dakota (7)
Northern California (2007)
Ohio (172)
Oklahoma (11)
Oregon (28)
Pennsylvania (1106)
Puerto Rico (10)
Rhode Island (30)
South America (998)
South Carolina (17)
Southern California (1751)
Tennessee (89)
Texas (745)
United States (18305)
Utah (115)
Virginia (147)
Washington D.C. (63)
Washington State (444)
West Virginia (3)
Wisconsin (54)
579,873 Results for "novum pharmaceutical research services".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research
April 24, 2025
·
3 min read
FDA
Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
Baxter International Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. Adding LVP modality to the Novum IQ Infusion Platform – which includes Baxter’s syringe infusion pump (SYR) with Dose IQ Safety Software, powered by the IQ Enterprise Connectivity Suite – enables clinicians to utilize a single, integrated system across a variety of patient care settings.
April 1, 2024
·
9 min read
Press Releases
American Academy of Dermatology Awards Podium Presentation to Phio Pharmaceutical’s Clinical Research at 2025 Annual Meeting
Interim Results from clinical study for cutaneous carcinomas presented at Late-Breaking Research Session
March 10, 2025
·
5 min read
Layoffs
Entrada Cuts 20% of Workforce, Targeting Research Employees
Entrada is paring back its research staff even as it gears up to hire employees to support a planned clinical trial for a Duchenne muscular dystrophy candidate.
April 30, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Columbus Rallies to Fund Life-Saving Research and Patient Care Services at Susan G. Komen® 2025 Race for the Cure
April 3, 2025
·
3 min read
Press Releases
Dovetail Genomics Announces Early Access Service for FFPE Sample Analysis, Enhancing Cancer Research Capabilities
February 26, 2025
·
4 min read
Press Releases
KLAS Research Ranks ScribeEMR ‘Best in KLAS for Virtual Scribing Services for Second Consecutive Year
Award to be Presented at HIMSS 2025 Global Health Conference, March 3, 7:30 pm PST
February 6, 2025
·
1 min read
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025
April 25, 2025
·
2 min read
Press Releases
Alamar Biosciences Launches Certified Service Provider Program to Expand Access to NULISA technology for Academic and Biopharmaceutical Researchers
February 21, 2025
·
2 min read
Press Releases
Rhythm Pharmaceuticals and Raymond A. Wood Foundation Announce Research Collaboration
March 18, 2025
·
3 min read
1 of 57,988
Next
